| Primary |
| Drug Use For Unknown Indication |
19.4% |
| Parkinson's Disease |
12.9% |
| Constipation |
9.7% |
| Dystonia |
9.7% |
| Epilepsy |
6.5% |
| Mental Disorder |
6.5% |
| Psychotic Disorder |
6.5% |
| Salivary Hypersecretion |
6.5% |
| Schizophrenia |
6.5% |
| Akathisia |
3.2% |
| Depression |
3.2% |
| Drug Abuser |
3.2% |
| Extrapyramidal Disorder |
3.2% |
| Parkinsonism |
3.2% |
|
| Vomiting |
17.6% |
| Dystonia |
11.8% |
| Confusional State |
5.9% |
| Dilatation Ventricular |
5.9% |
| Disorientation |
5.9% |
| Hyponatraemia |
5.9% |
| Liver Function Test Abnormal |
5.9% |
| Mitral Valve Disease |
5.9% |
| Overdose |
5.9% |
| Sepsis |
5.9% |
| Suicidal Ideation |
5.9% |
| Therapeutic Agent Toxicity |
5.9% |
| Weight Increased |
5.9% |
| Wrong Drug Administered |
5.9% |
|
| Secondary |
| Maternal Exposure Before Pregnancy |
50.0% |
| Foetal Exposure During Pregnancy |
11.2% |
| Psychotic Disorder |
10.2% |
| Epilepsy |
7.1% |
| Product Used For Unknown Indication |
5.1% |
| Blood Cholesterol |
3.1% |
| Depression |
3.1% |
| Adverse Event |
2.0% |
| Ill-defined Disorder |
2.0% |
| Schizophrenia |
1.5% |
| Schizophrenia, Paranoid Type |
1.5% |
| Contraception |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Akathisia |
0.5% |
| Extrapyramidal Disorder |
0.5% |
|
| Weight Increased |
30.8% |
| Pierre Robin Syndrome |
15.4% |
| Maternal Exposure Before Pregnancy |
10.3% |
| Respiratory Disorder |
10.3% |
| Adverse Drug Reaction |
2.6% |
| Death |
2.6% |
| Drug Toxicity |
2.6% |
| Ileus |
2.6% |
| Increased Appetite |
2.6% |
| Learning Disability |
2.6% |
| Learning Disorder |
2.6% |
| Maternal Drugs Affecting Foetus |
2.6% |
| Pain |
2.6% |
| Pulmonary Congestion |
2.6% |
| Skin Injury |
2.6% |
| Suicidal Ideation |
2.6% |
| Urinary Retention |
2.6% |
|
| Concomitant |
| Schizophrenia |
29.4% |
| Drug Use For Unknown Indication |
11.7% |
| Schizophrenia, Paranoid Type |
8.9% |
| Bipolar Disorder |
6.7% |
| Parkinson's Disease |
6.7% |
| Extrapyramidal Disorder |
5.6% |
| Psychotic Disorder |
4.4% |
| Schizoaffective Disorder |
3.9% |
| Product Used For Unknown Indication |
3.3% |
| Neurogenic Bladder |
2.8% |
| Anxiety |
2.2% |
| Depression |
2.2% |
| Hypertension |
2.2% |
| Schizophrenia, Catatonic Type |
2.2% |
| Blood Pressure Increased |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Affective Disorder |
1.1% |
| Atrial Flutter |
1.1% |
| Cardiovascular Disorder |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Weight Increased |
12.3% |
| Urinary Retention |
8.2% |
| Tremor |
6.8% |
| White Blood Cell Count Decreased |
6.8% |
| Death |
5.5% |
| Pathological Gambling |
5.5% |
| Platelet Count Decreased |
5.5% |
| Somnolence |
5.5% |
| White Blood Cell Count Increased |
5.5% |
| Liver Function Test Abnormal |
4.1% |
| Neoplasm Malignant |
4.1% |
| Neutropenia |
4.1% |
| Sexual Dysfunction |
4.1% |
| Speech Disorder |
4.1% |
| Vision Blurred |
4.1% |
| Alanine Aminotransferase Increased |
2.7% |
| Bipolar Disorder |
2.7% |
| Blindness |
2.7% |
| Drug Dispensing Error |
2.7% |
| Hyperglycaemia |
2.7% |
|
